Building Competency in Diabetes Education THE ESSENTIALS

TREATMENT MODALITIES: PHARMACOLOGICAL THERAPIES | 6-126

34. DeFronzo RA, Eldor R, Abdul-Ghani M. Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care 2013;36(Suppl 2):S127-S138. 35. Matthews DR. The natural history of diabetes-related complications: The ULPDS experience. United Kingdom Prospective Diabetes Study. Diabetes Obes Metab 1999:1(Suppl 2):S7-S13. 36. DeFronzo RA, Triplitt CL, Abdul-Ghani M, et al. Novel agents for the treatment of type 2 diabetes. Diabetes Spectr 2014;27:100-12. 37. Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study Group. JAMA 1999;281:2005-12. 38. Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties. Ottawa: CPA, 2018. 39. Kushner P. Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2011;3:49-53. 40. Montori VM, Dinneen SFB. Currently available oral hypoglycemic agents for type 2 diabetes mellitus. In Gerstein HC, Hayes RB, eds. Evidence-Based Diabetes Care. Hamilton: BC Decker, 2001:277-94. 41. Sanofi-Aventis Canada Inc. Glucophage Product Monograph. Laval: Sanofi-Aventis Canada, 2018. 42. Garber AJ, Abrahamson MJ, Barzilay JI, et al. AACE/ACE Consensus Statement Type 2 Diabetes Management - 2018 Executive Summary. Endocr Pract 2018;24:91-120. 43. Munshi M. NEW UpToDate 2018. Treatment of yype 2 diabetes mellitus in the older patient. https://www.uptodate.com/contents/treatment-of-type-2-diabetes-mellitus-in- the-older-patient/print. Accessed January 29. 2019. 44. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):1-68. 45. Triplitt C. Drug interactions of medications commonly used in diabetes. Diabetes Spectr 2006;19:202-11. 46. Chaudhury A, Duvoor C, Reddy Dendy DS, et al. Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Front Endocrinol (Lausanne) 2017;8:6.